Outsourced Compounded Preparation

SUNY Upstate Medical University intends to purchase 503B compounded pharmaceuticals from Fagron Sterile Services a contract awarded by Premier pursuant to its authority under section 163 (3) (vi), which authorizes the purchases of commodities from a consortium or comparable entity in lieu of using a centralized contract and without a formal competitive process when justified by price. Vendors who sell equivalent 503B compounded pharmaceuticals by Fagron Sterile Services may, if interested, contact Michael Cushner to discuss the procurement.

Equivalency must be demonstrated by meeting the clinical performance of the 503B compounded pharmaceuticals by Fagron Sterile Services. If offering a clinical equivalent, the vendor must provide free supporting clinical documentation, and equipment for examination, demonstration, and trial. Vendor must be authorized to see the 503B compounded pharmaceuticals from Fagron Sterile Services as listed on the Premier contract or approved equivalent.

This procurement is subject to NYS Finance Law §139 j&k, AKA the Lobbying Law. Therefore, vendors are cautioned that the only permissible contact for this procurement is the individual listed below. Contacting any other individuals at Upstate in connection with this advertisement may constitute a violation of New York State Finance Law. Failure to comply with this requirement can range from no contract award to debarment from sales to any NYS Agency.

Successful contractor shall be required to submit valid and current NYS “Workman’s Compensation and Disability Forms.

Anyone who can provide the above describe product is invited to contact SUNY Upstate Medical University’s Hospital Purchasing Department as shown below.